190 related articles for article (PubMed ID: 36266214)
41. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
42. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
[TBL] [Abstract][Full Text] [Related]
43. Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lee E; Khavanin N; He W; Darrach H; Kraenzlin F; Jenny H; Yang R; Sacks JM
Plast Reconstr Surg; 2020 Jul; 146(1):30-37. PubMed ID: 32590638
[TBL] [Abstract][Full Text] [Related]
44. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
[TBL] [Abstract][Full Text] [Related]
45. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
46. Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: a UK case report.
Sørensen K; Murphy J; Lennard A; Wadehra V; Menon GK; Collis N
J Plast Reconstr Aesthet Surg; 2014 Apr; 67(4):561-3. PubMed ID: 24156878
[TBL] [Abstract][Full Text] [Related]
47. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Invasive Chest Wall Masses.
Coombs DM; Aliotta R; Jagadeesh D; Raymond D; Isakov R
Ann Plast Surg; 2021 Oct; 87(4):409-414. PubMed ID: 34176904
[TBL] [Abstract][Full Text] [Related]
48. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
[TBL] [Abstract][Full Text] [Related]
49. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
[TBL] [Abstract][Full Text] [Related]
50. Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
Kadin ME; Morgan J; Xu H; Glicksman C; Sieber D; Adams WP; McGuire P; Clemens MW; Thakur A; Lum LG
Aesthet Surg J; 2021 Nov; 41(12):1359-1364. PubMed ID: 33165542
[TBL] [Abstract][Full Text] [Related]
51. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
52. The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients.
Campanale A; Spagnoli A; Lispi L; Boldrini R; Marletta M
Plast Reconstr Surg; 2020 Nov; 146(5):530e-538e. PubMed ID: 32852469
[TBL] [Abstract][Full Text] [Related]
53. European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey.
Villarroya-Marquina I; Moshrefi S; Sheckter C; Lee GK
Aesthetic Plast Surg; 2020 Oct; 44(5):1387-1395. PubMed ID: 32367324
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: Management of cytological sample by an integrated approach.
Ronchi A; Montella M; Argenzio V; Lucia A; De Renzo A; Alfano R; Franco R; Cozzolino I
Cytopathology; 2018 Jun; 29(3):294-299. PubMed ID: 29633403
[TBL] [Abstract][Full Text] [Related]
55. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
56. A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations.
Fracol ME; Rodriguez MM; Clemens MW
Clin Plast Surg; 2023 Apr; 50(2):249-257. PubMed ID: 36813403
[TBL] [Abstract][Full Text] [Related]
57. Breast magnetic resonance imaging (BMRI) in the diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): Findings beyond late seroma.
Fleury EFC
Breast J; 2020 Jul; 26(7):1382-1384. PubMed ID: 32166789
[No Abstract] [Full Text] [Related]
58. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
[TBL] [Abstract][Full Text] [Related]
59. A practical cytological approach to the diagnosis of breast-implant associated anaplastic large cell lymphoma.
Barbé E; de Boer M; de Jong D
Cytopathology; 2019 Jul; 30(4):363-369. PubMed ID: 30628128
[TBL] [Abstract][Full Text] [Related]
60. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process.
Kim B; Roth C; Young VL; Chung KC; van Busum K; Schnyer C; Mattke S
Plast Reconstr Surg; 2011 Sep; 128(3):629-639. PubMed ID: 21502904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
